Heterocyclic Dicarbonyl Synthesis
Tech ID
P27-1379
Patent Status
Granted in India
Design Status
--
Technical Description
The present invention relates to the heterocyclic substituted dicarbonyl compound. It introduces piperazine, piperidine, and indole-substituted α-ketoamides as amyloid-beta aggregation modulators, promoting stable fibril formation and slowing aggregation kinetics.
Problems Addressed
- Alzheimer’s Disease Treatment Gap
- Complex Process
- Rising Neurological Disorders
- Complicated Structure
TARGET AUDIENCE
- Medical and Healthcare Sector
- Drug formulation Industry
- Pharmaceuticals Industry
- Research & Development
TECH FEATURES
- Novel Compound
- Chemo-Selective Reduction
- Flexible Structure
- Optimized Reaction
- High Therapeutic Potential
- Improved Efficacy
- Amyloid-beta Aggregation Modulator
P27-1379
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com